2021-01-06,Aerpio Pharmaceuticals (ARPO) Sees Hammer Chart Pattern: Time to Buy?
2021-01-06,Aerpio (ARPO) Seeks Strategic Options for Pipeline Programs
2021-01-05,Aerpio Announces Strategic Review after Topline Results from Razuprotafib Glaucoma Phase 2 Trial
2021-01-04,"Ultragenyx (RARE) Surges on Product Approvals, Pipeline Progress"
2020-12-31,Arcturus (ARCT) to Develop ARCT-032 for Cystic Fibrosis
2020-12-30,Novo Nordisk (NVO) Files for Ozempic's Label Expansion in EU
2020-12-28,Apellis' (APLS) Pipeline Candidate Pegcetacoplan Promising
2020-12-24,Bristol Myers' (BMY) CNS Phase III Cancer Study on Opdivo Fails
2020-12-23,Roche's (RHHBY) Phesgo Gets EU Nod to Treat Breast Cancer
2020-12-22,ChemoCentryx (CCXI) Reports Positive Top-Line Rare Disease Data
2020-12-21,Novo Nordisk (NVO) Files for Semaglutide Label Expansion in EU
2020-12-18,"Ultragenyx (RARE), Mereo Ink Deal for Bone Disease Candidate"
2020-12-16,Novartis' (NVS) Entresto Gets FDA Panel Nod for Expanded Use
2020-12-15,Sangamo Therapeutics (SGMO) Catches Eye: Stock Jumps 6.5%
2020-12-15,Roche (RHHBY) Gets FDA Nod for Shorter Infusion Time of Ocrevus
2020-12-14,Seagen (SGEN) Gets Positive CHMP Opinion for Breast Cancer Drug
2020-12-14,Bristol Myers (BMY) Gets Positive CHMP Opinion for Inrebic
2020-12-14,"What Makes Aerpio Pharmaceuticals, Inc. (ARPO) a Strong Momentum Stock: Buy Now?"
2020-12-11,Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial
2020-12-11,"Alkermes (ALKS) Outlines Value Enhancement Plan, Shares Up"
2020-12-10,Ultragenyx (RARE) Gets Orphan Drug Tag for Wilson Disease Drug
2020-12-09,Sesen Bio (SESN) Surges: Stock Moves 7.8% Higher
2020-12-09,"Checkmate (CMPI), Bristol Myers Ink Deal for Cancer Combo"
2020-12-08,Chimerx's (CMRX) NDA for Brincidofovir Accepted by FDA
2020-12-07,FDA Approves Label Expansion of Novo Nordisk's (NVO) Saxenda
2020-12-07,FDA Approves Label Expannsion of Novo Nordisk's (NVO) Saxenda
2020-12-07,Bayer (BAYRY) Inks Deal With Atara for CAR-T Cell Therapies
2020-12-04,Alnylam (ALNY) Ends Enrollment in Advanced Hyperoxaluria Study
2020-12-04,Five Star (FVE) in Focus: Stock Moves 5.8% Higher
2020-12-04,"Deere & Co, Chico's FAS, Aerpio Pharmaceuticals, TRACON Pharmaceuticals and Repligen Corp highlighted as Zacks Bull and Bear of the Day"
2020-12-03,Is Aerpio Pharmaceuticals (ARPO) A Good Stock To Buy Now?
2020-12-03,BioNTech (BNTX) Surges: Stock Moves 6.2% Higher
2020-11-15,"Introducing Aerpio Pharmaceuticals (NASDAQ:ARPO), The Stock That Zoomed 214% In The Last Year"
2020-11-10,Aerpio Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-05,Aerpio Pharmaceuticals to Report Third Quarter 2020 Financial Results on November 10
2020-11-05,Aerpio Hosting Key Opinion Leader Call on New Therapeutic Agents for COVID-19
2020-10-26,11 Stocks Moving In Monday's After-Hours Session
2020-10-26,Aerpio Announces First Patient Dosed with Razuprotafib in the Phase 2 Trial for the Prevention and Treatment of ARDS in Patients with Moderate-to-Severe COVID-19
2020-09-17,Aravive Appoints Michael W. Rogers to Board of Directors
2020-09-15,Aerpio Announces Enrollment Completed in the 28-Day Phase 2 Razuprotafib Glaucoma Trial
2020-09-01,Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients
2020-09-01,Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the I-SPY COVID Trial to Treat ARDS in Critically-ill COVID-19 Patients
2020-08-17,Here's Why We're Not Too Worried About Aerpio Pharmaceuticals' (NASDAQ:ARPO) Cash Burn Situation
2020-08-12,Aerpio Reports Second Quarter 2020 Financial Results and Provides Business Update
2020-08-10,Aerpio Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 12
2020-08-05,"The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings"
2020-08-04,"Aerpio Pharmaceuticals, Inc. Announces a Second Clinical Trial with Funding from MTEC to Evaluate Razuprotafib for the Prevention and Treatment of ARDS in Patients with Moderate to Severe COVID-19"
2020-06-29,"Aerpio Pharmaceuticals, Inc. (ARPO) Outpaces Stock Market Gains: What You Should Know"
2020-06-29,Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?
2020-06-24,Aerpio Announces Initiation of 28-Day Phase 2 Razuprotafib Glaucoma Trial
2020-06-22,"Aerpio Pharmaceuticals' Shares March Higher, Can It Continue?"
2020-06-19,"Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know"
2020-06-19,Top Ranked Momentum Stocks to Buy for June 19th
2020-06-15,New Strong Buy Stocks For June 15th
2020-06-15,Leap Therapeutics (LPTX) Soars: Stock Adds 8.3% in Session
2020-06-12,Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year?
2020-06-08,Aerpio Announces Change to Virtual Format for its 2020 Annual Meeting of Stockholders due to COVID-19
2020-06-08,Aerpio Hosting Key Opinion Leader Call on a Novel Mechanism for the Treatment of Glaucoma
2020-06-05,New Strong Buy Stocks For June 5th
2020-05-29,"Company News for May 29, 2020"
2020-05-29,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant"
2020-05-27,"Aerpio Pharmaceuticals, Inc. and Quantum Leap Healthcare Collaborative Announce the Selection of Razuprotafib for Evaluation in the I-SPY COVID Trial for the Treatment of Acute Respiratory Distress Syndrome in COVID-19 Patients"
2020-05-27,Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?
2020-05-26,New Strong Buy Stocks For May 26th
2020-05-21,"Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Strong Buy: Here's Why"
2020-05-21,New Strong Buy Stocks For May 21st
2020-05-13,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter"
2020-05-12,Aerpio Announces Amended Licensing Deal with Gossamer Bio on its Inflammatory Bowel Disease (IBD) Product Candidate GB004 (formerly AKB-4924)
2020-05-11,Is Aerpio Pharmaceuticals (ARPO) Stock Outpacing Its Medical Peers This Year?
2020-05-07,Aerpio Reports First Quarter 2020 Financial Results and Provides Business Update
2020-05-06,"Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know"
2020-04-24,New Strong Buy Stocks for April 24th
2020-04-22,"Aerpio Pharmaceuticals, Inc. (ARPO) Gains But Lags Market: What You Should Know"
2020-04-22,Has Aerpio Pharmaceuticals (ARPO) Outpaced Other Medical Stocks This Year?
2020-04-20,New Strong Buy Stocks For April 20th
2020-04-16,Immunovant (IMVT) Catches Eye: Stock Jumps 5%
2020-04-09,"Does Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) Have A High Beta?"
2020-04-08,"Aerpio Pharmaceuticals, Inc. (ARPO) Moves to Strong Buy: Rationale Behind the Upgrade"
2020-03-16,Aerpio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
2020-03-12,"Aerpio Pharmaceuticals to Report Year Ended December 31, 2019 Financial Results on Monday, March 16, 2020"
2020-02-09,Those Who Purchased Aerpio Pharmaceuticals (NASDAQ:ARPO) Shares A Year Ago Have A 80% Loss To Show For It
2020-02-07,Aerpio Pharmaceuticals Presents Data from Fifth Patient Cohort Showing Potential of Topical Ocular Formulation of AKB-9778 Product Candidate When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension
2020-01-08,Topical Ocular Formulation of Aerpio Pharmaceuticals AKB-9778 Product Candidate Produced IOP Lowering with Minimal Hyperemia When Combined with Prostaglandin in Subjects with Primary Open Angle Glaucoma or Ocular Hypertension in Phase 1b Trial
2019-12-22,"Hedge Funds Are Buying Aerpio Pharmaceuticals, Inc. (ARPO)"
2019-11-11,Here's Why We're A Bit Worried About Aerpio Pharmaceuticals's (NASDAQ:ARPO) Cash Burn Situation
2019-11-07,Aerpio Reports Third Quarter 2019 Financial Results and Provides Business Update
2019-10-21,"Cincinnati firms stock jumps amid C-suite shakeup, possibility of sale or merger"
2019-10-21,Aerpio Pharmaceuticals Announces Review of Strategic Alternatives
2019-10-10,Aerpio Pharmaceuticals Announces Interim Results from its Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
2019-10-09,"All You Need to Know About Aerpio Pharmaceuticals, Inc. (ARPO) Rating Upgrade to Buy"
2019-08-14,Cincinnati stocks hammered as Dow suffers fourth-biggest drop
2019-08-08,Aerpio Reports Second Quarter 2019 Financial Results and Provides Business Update
2019-07-05,This Cincinnati stock gained 457% in the first half of 2019: SLIDESHOW
2019-06-10,Aerpio Initiates Phase 1b Clinical Trial of Topical Ocular Formulation of AKB-9778 for Primary Open Angle Glaucoma
2019-05-14,Wall Street Sees 3 Falling Knives Rebounding Within 52 Weeks
2019-05-09,Aerpio Reports First Quarter 2019 Financial Results and Provides Business Update
2019-05-02,"Aerpio Pharmaceuticals Presents Data Showing Potential of AKB-9778, a VE-PTP Inhibitor/Tie2 Activator, to Lower Intra-ocular Pressure in Human Subjects"
2019-04-25,"Aerpio Pharmaceuticals to Present Data Demonstrating Role of VE-PTP in Conventional Outflow Homeostasis and the Potential of AKB-9778, a VE-PTP Inhibitor/Tie2 Activator, as a Treatment for Open-Angle Glaucoma"
2019-04-09,"Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Buy: What Does It Mean for the Stock?"
2019-04-05,Aerpio Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference
